Melanoma of unknown origin: A case series

Irish Journal of Medical Science

Volumn 179, Issue 4, 2010, Pages 629-632

  Kelly, J ^a   Redmond, H P ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

Melanoma; Metastatic melanoma; Unknown primary

Indexed keywords

ALPHA2B INTERFERON; BCG VACCINE;

ADJUVANT THERAPY; ARTICLE; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IDIOPATHIC DISEASE; LYMPH NODE; LYMPHADENOPATHY; MELANOMA; POSITRON EMISSION TOMOGRAPHY; SURGICAL APPROACH;

ADULT; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY;

EID: 78349309664     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-009-0405-6     Document Type: Article

References (13)

1. KK Anbari LM Schuchter LP Bucky, et al. 1997 Melanoma of unknown primary site: presentation, treatment, and prognosis-a single institution study. University of Pennsylvania Pigmented Lesion Study Group Cancer 79 1816 1821 1:STN:280:DyaK2s3nsFWjtQ%3D%3D 10.1002/(SICI)1097-0142(19970501)79:9<1816:: AID-CNCR26>3.0.CO;2-# 9129001
2. KA Katz E Jonasch FS Hodi, et al. 2005 Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute Melanoma Res 15 77 82 10.1097/00008390-200502000-00013 15714125
3. CM Balch AC Buzaid SJ Soong, et al. 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D 11504745
4. VS Yee JF Thompson JG McKinnon, et al. 2005 Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy Ann Surg Oncol 12 429 439 10.1245/ASO.2005.03.074 15886905
5. B Schlagenhauff W Stroebel U Ellwanger, et al. 1997 Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations Cancer 80 60 65 1:STN:280:DyaK2szlsVCitw%3D%3D 10.1002/(SICI)1097-0142(19970701)80:1<60::AID- CNCR8>3.0.CO;2-J 9210709
6. IA Ho Shon DK Chung RP Saw JF Thompson 2008 Imaging in cutaneous melanoma Nucl Med Commun 29 847 876 10.1097/MNM.0b013e32830439fb 18769303
7. J Horn J Lock-Andersen H Sjostrand A Loft 2006 Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy Eur J Nucl Med Mol Imaging 33 887 892 10.1007/s00259-006-0077-7 16586078
8. A Eigtved AP Andersson K Dahlstrom, et al. 2000 Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma Eur J Nucl Med 27 70 75 1:STN:280: DC%2BD3c7hvFKntA%3D%3D 10.1007/PL00006666 10654150
9. H Jadvar DL Johnson GM Segall 2000 The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma Clin Nucl Med 25 48 51 1:STN:280:DC%2BD3c%2Fpsl2qtQ%3D%3D 10.1097/00003072-200001000-00011 10634531
10. J Kelly M Leader P Broe 2007 Primary malignant melanoma of the oesophagus: a case report J Med Case Rep 1 50 10.1186/1752-1947-1-50
11. B Kenney J Dotto R Homer N Shafi L Davydova 2007 Primary malignant melanoma of the transverse colon: report of a case and review of the literature Int J Surg Pathol 15 401 407 10.1177/1066896907302370 17913951
12. BS Ooi KW Eu F Seow-Choen 2001 Primary anorectal malignant melanoma: clinical features and results of surgical therapy in Singapore-a case series Ann Acad Med Singap 30 203 205 1:STN:280:DC%2BD3M3psVaqtQ%3D%3D 11379420
13. JM Kirkwood JG Ibrahim VK Sondak, et al. 2000 High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190 J Clin Oncol 18 2444 2458 1:CAS:528:DC%2BD3cXkvFWrsbo%3D 10856105